Erectile Dysfunction and Ejaculatory Dysfunction in Covid-19 Recovered Patient: Temporary or Persistent?

Area of Science:

• Urology
• Infectious Diseases
• Sexual Health

Background:

• COVID-19 infection has been linked to various long-term health issues.
• Sexual dysfunction is a potential post-viral complication affecting quality of life.

Purpose of the Study:

• To determine the prevalence of erectile dysfunction (ED) and ejaculatory dysfunction (EJD) in patients recovered from COVID-19.
• To assess the temporal changes and potential improvement of these sexual dysfunctions over time.

Main Methods:

• A retrospective study involving 50 male patients hospitalized with COVID-19.
• Evaluation of erectile and ejaculation function using the International Index of Erectile Function 5 (IIEF-5) and Male Sexual Health Questionnaire Ejaculatory Dysfunction (MHSQ-EJD) via phone interviews.
• Statistical analysis to compare IIEF-5 and MHSQ-EJD scores at different time points post-infection (0-6 months, 6-12 months, >24 months).

Main Results:

• The prevalence of ED was 70% and EJD was 2% within 0-6 months after COVID-19 infection.
• A statistically significant difference in IIEF-5 scores was observed across the three time periods, indicating improvement.
• Mean age of patients was 50.4 years, with common comorbidities including hypertension (24%) and diabetes (8%).

Conclusions:

• Erectile dysfunction is highly prevalent among COVID-19 recovered patients.
• Both erectile and ejaculatory dysfunctions appear to be temporary conditions that can improve over time post-COVID-19 recovery.